Sterigenics to triple West Memphis sterilisation capacity

Company commits to meeting customer needs with US$15m expansion

Sterigenics International, the leading global provider of contract sterilisation, gamma technologies and medical isotopes, and a portfolio company of Warburg Pincus and GTCR, has announced a US$15m expansion at its West Memphis (Arkansas, US) facility that will triple the company’s gamma sterilisation capacity.

Opened in 1999, the West Memphis Sterigenics facility currently offers 2.5 million cubic feet of gamma sterilisation capacity. The installation of a new gamma cell will triple its capacity to 7.5 million cubic feet and, on completion in early 2017, will result in approximately 20 additional jobs at full capacity.

‘As the demand for medical devices grows globally, our customers can be assured that we will add sterilisation capacity to meet their needs,’ said Michael Mulhern, CEO of Sterigenics International. ‘The expansion at West Memphis is just one more example of our ongoing commitment to customers.’

‘Our West Memphis location is experiencing increasing demand for sterilisation services,’ said Philip Macnabb, President of Sterigenics International. ‘Given the importance of Memphis as a major US logistics hub, it is a critical piece of our global network that we will continue to build on and expand.’

Companies